Spots Global Cancer Trial Database for gastrointestinal tumor
Every month we try and update this database with for gastrointestinal tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours | NCT06022692 | Gastrointestina... | Water-filtered ... tislelizumab (B... | 18 Years - 75 Years | Zhejiang Hospital | |
Study on TIL for the Treatment of r/r Gastrointestinal Tumors | NCT04960072 | Gastrointestina... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
Phase I Trial of Combination of FOLFIRI and SOM 230 | NCT01434069 | Gastrointestina... | SOM230C LAR FOLFIRI Infusio... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors | NCT04960943 | Gastrointestina... Effect of Drug | Pyrotinib with ... | 18 Years - | Fudan University | |
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas | NCT01625351 | Ewing Sarcoma Gastrointestina... Germ Cell Tumor Hepatic Tumor Lymphoma Wilms Tumor Rhabdoid Tumor Clear Cell Carc... Renal Cell Carc... Melanoma Neuroblastoma Rhabdomyosarcom... Non-rhabdomyosa... | alemtuzumab fludarabine sirolimus Busulfan melphalan stem cells CliniMACS | 2 Years - 21 Years | St. Jude Children's Research Hospital | |
Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors | NCT04960943 | Gastrointestina... Effect of Drug | Pyrotinib with ... | 18 Years - | Fudan University | |
Study on TIL for the Treatment of r/r Gastrointestinal Tumors | NCT04960072 | Gastrointestina... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope | NCT06340620 | Pancreatic Dise... Pancreatic Canc... Pancreatic Cyst Gastrointestina... Bile Duct Disea... Bile Duct Cance... Lymph Node Dise... Submucosal Tumo... Gastrointestina... | Endoscopic ultr... | 18 Years - 100 Years | Orlando Health, Inc. | |
Study on TIL for the Treatment of r/r Gastrointestinal Tumors | NCT04960072 | Gastrointestina... | Tumor Infiltrat... | 18 Years - 75 Years | Shanghai Juncell Therapeutics | |
Transcutaneous Electrical Acupoint Stimulation for Postoperative Cognitive Dysfunction | NCT04606888 | Postoperative C... | Transcutaneous ... | 60 Years - 90 Years | Subei People's Hospital of Jiangsu Province | |
Hyperthermia Combined With Immune Checkpoint Inhibitor Therapy for Advanced Gastrointestinal Tumours | NCT06022692 | Gastrointestina... | Water-filtered ... tislelizumab (B... | 18 Years - 75 Years | Zhejiang Hospital | |
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma | NCT02631590 | Biliary Carcino... Gall Bladder Ca... Cholangiocarcin... Gastrointestina... | Cisplatin Gemcitabine Copanlisib | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor | NCT05262491 | Gastrointestina... | BL-B01D1 | 18 Years - 75 Years | Sichuan Baili Pharmaceutical Co., Ltd. |